# KIMS (KIMS) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/kims

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹807.3
- Change: +1.95%
- As of: 2026-09-18
- 1D return: +2.27%
- 5D return: +4.79%
- 1M return: +2.51%
- Latest complete quarter: fy27_q1

## Faxioms Analysis

_As of 2026-09-18_

### Technical Outlook

As of September 18, 2026, KIMS is trading at ₹809.85. The stock exhibits a mixed technical picture across different timeframes. Daily indicators suggest a potential weakening trend, with the Super Trend indicator in a bearish state and the 5-day slope of the 20-day Simple Moving Average (SMA) showing a negative trend. However, the price remains above key daily moving averages including the 20-day Exponential Moving Average (EMA) and 200-day SMA. In contrast, weekly and monthly timeframes present a more constructive outlook, with Super Trend indicators in a bullish state and the price trading above relevant moving averages on both periods. Recent active patterns include a "Bullish Engulfing Reversal" and "Morning Star" on the monthly and weekly charts respectively, suggesting potential upside.

The stock is currently positioned near its nearest support level at ₹806.25, which is approximately 0.44% below the current price. Key resistance is observed around ₹820.65, about 1.33% higher. The stock's recent trading history includes a "wide intraday range" anomaly on September 17, 2026, with a significant upward price movement. Volatility remains a factor, with an annualized volatility of 32% and a current drawdown of -5%.

- Nearest support level observed at ₹806.25.
- Nearest resistance level observed at ₹820.65.
- Daily trend shows bearish signals (Super Trend) while weekly and monthly trends are bullish.
- Active bullish reversal patterns noted on monthly and weekly charts.
- Watch for price movement relative to the ₹820.65 resistance and ₹806.25 support levels.

- Bullish Engulfing Reversal
- Morning Star
- Outside Bar
- Doji

### News Context

Krishna Institute of Medical Sciences Limited (KIMS) has been active in investor engagement and strategic expansion over the past week. The company announced an Operations and Management Agreement with Sarvottam Health Care Private Limited (SHPL) on September 10, 2026. This five-year agreement, with an option for a further five-year extension, involves KIMS managing SHPL's 183-bed hospital in Kakinada, Andhra Pradesh. Under this arrangement, KIMS will receive a revenue fee equivalent to 9% of SHPL's total net revenue, aiming to expand KIMS's regional presence.

In parallel, KIMS has scheduled multiple investor and analyst meetings. These include a meeting hosted by Emkay Global Group on September 10, 2026, and participation in the J.P. Morgan India Conference on September 21, 2026, and the Anand Rathi Annual Flagship Conference G-200 Summit 2026 on September 22, 2026. The company has stated that no unpublished price-sensitive information will be disclosed during these sessions, and schedules are subject to change.

- On September 10, 2026, KIMS entered an Operations and Management Agreement with Sarvottam Health Care Private Limited to manage its 183-bed hospital in Kakinada, Andhra Pradesh, for an initial five-year term.
- Under the agreement, KIMS will receive 9% of Sarvottam Health Care's total net revenue.
- KIMS participated in an institutional investor meeting hosted by Emkay Global Group on September 10, 2026.
- The company is scheduled to attend investor meetings at the J.P. Morgan India Conference on September 21, 2026, and the Anand Rathi Annual Flagship Conference on September 22, 2026.
- KIMS has confirmed that no unpublished price-sensitive information will be shared during these upcoming investor interactions.

- Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL
- Krishna Institute of Medical Sciences Limited has informed the Exchange about entering into an Operations and Management Agreement with Sarvottam Health Care Private Limited, Kakinada, Andhra Pradesh |SUBJECT: Agreements
- Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates

### What Changed

As of September 18, 2026, Krishna Institute of Medical Sciences (KIMS) on the NSE saw its stock price increase to ₹809.85 from a previous price of ₹791.85. The provided evidence does not detail any new filings or news developments for the company. The daily and weekly trends for the stock are not specified in the recent data.

- On 2026-09-18, KIMS stock closed at ₹809.85.
- The stock price was ₹791.85 prior to the latest observation date.
- No new filings were reported for KIMS as of 2026-09-18.
- No news developments were reported for KIMS as of 2026-09-18.

### Official Filings

Krishna Institute of Medical Sciences Limited (KIMS) has entered into an Operations and Management Agreement with Sarvottam Health Care Private Limited (SHPL) to manage SHPL's 183-bed hospital in Kakinada, Andhra Pradesh. This five-year agreement, with an option for a further five-year extension, will see KIMS receive a revenue fee equivalent to 9% of SHPL's total net revenue. This arrangement allows KIMS to expand its regional presence and manage hospital operations exclusively. The company also clarified on August 26, 2026, that reports from August 25, 2026, regarding a potential acquisition of a stake in Renova Hospitals for $52 million were false and baseless, stating no such discussions or agreements were in place. KIMS held its 24th Annual General Meeting on August 27, 2026, where financial statements for the year ended March 31, 2026, were adopted, and a director was re-appointed. Additionally, the company reported the allotment of 7,702,182 fully convertible warrants on August 19, 2026, following a preferential issue. KIMS has also scheduled several investor and analyst meetings in September 2026, including sessions at the J.P. Morgan India Conference on September 21, 2026, and the Anand Rathi Annual Flagship Conference on September 22, 2026. These meetings will not involve the disclosure of unpublished price-sensitive information.

- On September 10, 2026, KIMS entered a 5-year Operations and Management Agreement with Sarvottam Health Care Private Limited for a 183-bed hospital in Kakinada, Andhra Pradesh, earning a 9% revenue fee.
- On August 26, 2026, KIMS denied reports of talks to acquire a stake in Renova Hospitals for $52 million, stating the claims were false.
- KIMS held its Annual General Meeting on August 27, 2026, adopting financial statements for the year ended March 31, 2026, and re-appointing a director.
- On August 19, 2026, KIMS allotted 7,702,182 fully convertible warrants via a preferential issue.
- KIMS scheduled investor and analyst meetings for September 21 and September 22, 2026, confirming no unpublished price-sensitive information will be disclosed.

- Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL
- Krishna Institute of Medical Sciences Limited has informed the Exchange about entering into an Operations and Management Agreement with Sarvottam Health Care Private Limited, Kakinada, Andhra Pradesh |SUBJECT: Agreements
- Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL
- Krishna Institute of Medical Sciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 27, 2026. Further, the company has informed the Exchange regarding voting results. |SUBJECT: Shareholders meeting
- Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 27, 2026 |SUBJECT: Shareholders meeting
- Krishna Institute of Medical Sciences Limited has informed the Exchange about Clarification regarding article appearing in Dealstreetasia.com dated 25th August 2026 titled ChrysCapital- backed KIMS in talks to acquire stake in Renova Hospitals for $52 Million |SUBJECT: General Updates
- Krishna Institute of Medical Sciences Limited has informed the Exchange regarding allotment of 7702182 fully convertible warrants securities pursuant to Preferential Issue |SUBJECT: Allotment of Securities

### Fundamentals

Krishna Institute of Medical Sciences (KIMS) reported revenue from operations of ₹1,179.50 crore for Q1 FY2026-27. This represents an increase from the ₹1,074.60 crore reported in Q4 FY2025-26 and ₹997.70 crore in Q3 FY2025-26. Profit Before Tax (PBT) for Q1 FY2026-27 was ₹55.60 crore, a decrease from ₹68.60 crore in Q3 FY2025-26, although it showed an increase from ₹52.20 crore in Q4 FY2025-26. Finance costs have shown a consistent upward trend, rising from ₹56.80 crore in Q3 FY2025-26 to ₹83.40 crore in Q1 FY2026-27. Basic and Diluted Earnings Loss Per Share (EPS) from continuing operations stood at ₹1.04 per share in Q1 FY2026-27, reflecting a decrease from ₹1.33 per share in Q3 FY2025-26 and ₹1.06 per share in Q4 FY2025-26. The increasing finance costs alongside a fluctuating PBT warrant monitoring in relation to revenue growth.

- Revenue from operations increased sequentially to ₹1,179.50 crore in Q1 FY2026-27.
- Profit Before Tax (PBT) was ₹55.60 crore in Q1 FY2026-27, up from Q4 FY2025-26 but down from Q3 FY2025-26.
- Finance Costs increased sequentially to ₹83.40 crore in Q1 FY2026-27.
- Basic and Diluted EPS from continuing operations were ₹1.04 per share in Q1 FY2026-27, a decrease from the prior two reported quarters.

### Bull Case

Krishna Institute of Medical Sciences (KIMS) exhibits several technical indicators suggesting positive momentum across different timeframes. On a weekly basis, the stock is trading above its 20-day and 50-day Simple Moving Averages (SMAs), with both SMAs showing an upward slope. The Supertrend indicator is also in a bullish direction on the weekly chart. This trend is supported by a positive 6-month return of 21% and a Year-to-Date (YTD) return of 31%. While the daily trend shows the Supertrend indicator in a bearish direction, the price is currently above its 20-day Exponential Moving Average (EMA) and the EMA itself has a positive slope, indicating some underlying strength.

- Weekly Supertrend indicator is bullish as of 2026-09-18.
- The stock has delivered a 6-month return of 21% and a YTD return of 31% as of 2026-09-18.
- On a weekly basis, the 20-day SMA slope is 30.29 and the 50-day SMA slope is 4.66, both indicating upward movement.
- The daily 20-day EMA slope is 3.85, suggesting a positive short-term trend.

### Bear Case

The company's stock is currently trading below its Super Trend indicator on a daily basis, which suggests a bearish short-term trend. While longer-term monthly trends remain bullish, the daily technicals indicate potential downward pressure. The stock has also experienced a drawdown of 5% from its recent peak, and its annualized volatility stands at 32%, highlighting a degree of price fluctuation. Furthermore, the Average True Range (ATR) at 2.59% suggests that the stock's price can move by this percentage on an average day, indicating potential for significant intraday price swings.

- The daily Super Trend indicator is 'bearish' as of 2026-09-18, with the closing price of ₹809.85 below the indicator level of ₹817.6.
- The stock has a current drawdown of -5%.
- Annualized volatility is recorded at 32%.
- The Average True Range (ATR) is 2.59%.

### FAQs

**What is the company's recent operational expansion strategy?**

On September 10, 2026, Krishna Institute of Medical Sciences Limited (KIMS) entered into an Operations and Management Agreement with Sarvottam Health Care Private Limited to manage its 183-bed hospital in Kakinada, Andhra Pradesh. Under this agreement, KIMS will receive a revenue fee equal to 9% of the hospital's total net revenue for an initial term of five years, with an option for a further five-year extension. This move expands KIMS's regional presence and grants it control over the hospital's operations.

**What are the recent technical indicators for Krishna Institute of Medical Sciences Limited?**

As of September 18, 2026, the daily trend for Krishna Institute of Medical Sciences Limited shows a closing price of ₹809.85. The 20-day Exponential Moving Average (EMA) is ₹777.09, and the 50-day EMA is ₹780.53. The Supertrend indicator is at ₹817.6, with a 'bearish' direction. On a monthly basis, the Supertrend is ₹486.24, indicating a 'bullish' direction. The weekly trend shows a Supertrend of ₹678.48, also in a 'bullish' direction.

**What recent investor engagement activities has Krishna Institute of Medical Sciences Limited undertaken?**

Krishna Institute of Medical Sciences Limited has scheduled several investor meetings in September 2026. These include a meeting on September 21, 2026, at the J.P. Morgan India Conference in Mumbai, and another on September 22, 2026, at the Anand Rathi Annual Flagship Conference G-200 Summit in Mumbai. Additionally, an institutional investor meeting was hosted by Emkay Global Group on September 10, 2026. The company has stated that no unpublished price-sensitive information will be disclosed during these sessions.

**What are the recent performance returns for Krishna Institute of Medical Sciences Limited?**

As of September 18, 2026, Krishna Institute of Medical Sciences Limited has shown varied returns across different periods. The year-to-date (YTD) return is 31%, and the return over the last 6 months is 21%. The return since the start of its trading history is 34%. Shorter-term returns include 1% for the last month, 3% for the last 3 months, and 5% for the last 10 days.

- Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL
- Krishna Institute of Medical Sciences Limited has informed the Exchange about entering into an Operations and Management Agreement with Sarvottam Health Care Private Limited, Kakinada, Andhra Pradesh |SUBJECT: Agreements
- Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
## Technical analytics

- As of: 2026-09-18
- Daily trend: Weak Uptrend
- Weekly trend: Moderate Uptrend
- Pivot point: ₹784.65
- Risk regime: Price Risk Currently Contained

### Support levels
- 730.45078125
- 623.496875
- 609.4496093749999

### Resistance levels
- 825.81875
- 858
- 820.65

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | +2.27% |
| return_10 | +5.47% |
| return_1m | +0.54% |
| return_1y | +9.39% |
| return_20 | +2.51% |
| return_3m | +2.55% |
| return_5 | +4.79% |
| return_6m | +20.51% |
| return_since_start | +34.23% |
| return_ytd | +31.45% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | contained_risk |
| label | Price risk currently contained |
| summary | Recent drawdown and price variability remain within the producer's contained-risk thresholds. |
| maximum_drawdown | -26.26% |
| annualized_volatility | +32.16% |

## Quarterly financials

- Latest complete quarter: fy27_q1

# Revenue Growth Accelerates, but Rising Finance Costs and Depreciation Weigh on Profitability

Krishna Institute of Medical Sciences Limited reported its highest quarterly revenue yet in the first quarter of fiscal 2026‑27, continuing a steady climb. However, profit before tax barely improved from the prior quarter and was half of what it earned a year ago. Finance costs rose sharply, and depreciation remained a large fixed charge, together absorbing much of the top‑line gain.

## Revenue Growth Continues

Revenue from operations has risen in each of the last five quarters:  
- Q1 FY26: ₹871.6 crore  
- Q2 FY26: ₹960.7 crore  
- Q3 FY26: ₹997.7 crore  
- Q4 FY26: ₹1,074.6 crore  
- Q1 FY27: ₹1,179.5 crore  

The latest quarter posted a 9.8% sequential increase and a 35.3% year‑on‑year jump. The pace of growth picked up compared with the prior two quarters, when sequential increases averaged around 6–8%.

## Profit Before Tax Lags

Profit before tax followed a different path. After reaching ₹113.7 crore in Q1 FY26, it fell to ₹96.8 crore, then ₹68.6 crore, and ₹52.2 crore in Q4 FY26, before edging up to ₹55.6 crore in Q1 FY27. The 51.1% year‑on‑year decline pushed the PBT margin from 13.0% of revenue to just 4.7%.

## Finance Costs Surge

Finance costs have risen each quarter:  
₹32.6 crore → ₹45.0 crore → ₹56.8 crore → ₹68.1 crore → ₹83.4 crore in Q1 FY27.  

The ₹15.3 crore increase between Q4 FY26 and Q1 FY27 alone was more than four times the ₹3.4 crore sequential pickup in profit before tax. Year‑on‑year, finance costs jumped 155.8%.

## Depreciation Adds to Cost Pressure

Depreciation expense for Q1 FY27 was ₹100.8 crore. Combined with finance costs, these two items totalled ₹184.2 crore — more than three times the quarter’s profit before tax of ₹55.6 crore.

## Other Expenses Form the Largest Cost Component

Total expenses, derived from revenue (₹1,179.5 crore) plus other income (₹16.4 crore) minus profit before tax (₹55.6 crore), amounted to ₹1,140.3 crore. The four separately reported expense lines — purchases of stock‑in‑trade (₹260.9 crore), employee benefit expense (₹212.6 crore), finance costs (₹83.4 crore), and depreciation (₹100.8 crore) — sum to ₹657.7 crore.  

The remaining expense of ₹482.6 crore, which is the largest single component, represents other operating costs not broken out in the disclosed numbers.

## Earnings Per Share Halved Year‑on‑Year

Basic earnings per share from continuing operations fell from ₹1.96 in Q1 FY26 to ₹1.04 in Q1 FY27, a decline of 46.9%. Sequentially, EPS moved only marginally, from ₹1.06 to ₹1.04.

## Management Commentary

KIMS Hospitals reported a robust start to FY27, with management highlighting strong demand trends as OP and IP footfalls grew 28.5% and 26.6% YoY respectively. CMD Dr. B Bhaskara Rao noted the addition of a new hospital in Palakkad and strong clinical performance across new units, including advanced procedures like lung transplants. The company continues to execute its expansion strategy, adding 787 beds in Kondapur and 208 in Palakkad during the quarter, with plans to add over 1,300 beds through greenfield, acquisitions, and O&M opportunities. Management expressed confidence in fulfilling FY27 targets, supported by sustained pricing power (ARPOB +9.7% YoY) and a track record of consistent growth.

## Key Takeaway

Revenue growth remained robust in Q1 FY27, but the benefit largely failed to reach the bottom line. A sharp rise in finance costs and a sizable depreciation charge kept profit before tax barely above the prior quarter and at only half the level of a year earlier. Earnings per share followed suit, halving year‑on‑year. The expense structure shows that the four reported cost lines account for less than three‑fifths of total expenses, leaving a large block of other operating costs that also weigh on profitability.

### Ratios

## Official filings

- 2026-09-15 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_15092026120857_Investor_call_21092026.pdf)
- 2026-09-15 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_19312_WebXMLFile_20260915_121231484.xml)
- 2026-09-15 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_15092026123306_Investor_call_22092026.pdf)
- 2026-09-10 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_10092026180003_Disclosure.pdf)
- 2026-09-07 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_07092026170950_Investorcall.pdf)
- 2026-09-07 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_19312_WebXMLFile_20260907_170604925.xml)
- 2026-08-30 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_30082026190517_KIMS_VR_Scrutinizers_Report_30082026_FINAL.pdf)
- 2026-08-27 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_27082026191816_Proceedings.pdf)
- 2026-08-26 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_26082026162658_Mediadisclosures.pdf)
- 2026-08-19 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_20082026005000_Allotment_warrants.pdf)
- 2026-08-08 — Official Filing: Krishna Institute of Medical Sciences Limited (KIMS Hospitals) reported Q1 FY27 total revenue of INR 1,196 crore, a 36.1% year-on-year increase, and EBITDA of INR 240 crore, up 20.1% year-on-year. The company raised INR 1,500 crore through a Qualified Institutional Placement (QIP), utilizing INR 1,100 crore to reduce debt, and also completed a preferential allotment to promoters for INR 600 crore. KIMS Hospitals opened a new unit in Palakkad, Kerala, and is focusing on stabilizing newly commissioned hospitals and achieving EBITDA positivity in units like Mahadevapura, Bangalore, which has already broken even.
- 2026-08-08 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_19312_WebXMLFile_20260808_225310555.xml)
- 2026-08-08 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_19312_WebXMLFile_20260808_222938574.xml)
- 2026-08-07 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_07082026211313_intimationfinal.pdf)
- 2026-08-06 — Generic Announcement: Krishna Institute of Medical Sciences Limited is complying with SEBI regulations by publishing a notice for its 24th Annual General Meeting. The meeting is scheduled for August 27, 2026, at 4:00 PM IST and will be conducted via Video Conferencing/Other Audio Visual Means. The notice has been published in Financial Express (English) and Navatelangana (Telugu) and is also available on the company's website. — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_06082026183522_newspaperfinal.pdf)
- 2026-08-05 — Generic Announcement: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/NOTICE_OF_SHAREHOLDERS_MEETINGS_19312_WebXMLFile_20260805_221258776.xml)
- 2026-08-05 — Generic Announcement: Krishna Institute of Medical Sciences Limited will hold its 24th Annual General Meeting on August 27, 2026, via video conference. The company has dispatched letters to members without registered email addresses, providing a web-link to the Annual Report for FY 2025-26, as required by SEBI Listing Regulations. This communication also serves as a reminder for security holders in physical form to update KYC details, including PAN, address, and bank information, by a cut-off date of July 31, 2026, to ensure eligibility for future payments. — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_05082026220244_ilovepdf_merged__13_.pdf)
- 2026-08-05 — Generic Announcement: Krishna Institute of Medical Sciences Limited will hold its 24th Annual General Meeting on August 27, 2026, via video conference. The agenda includes adopting the audited financial statements for FY 2025-26, re-appointing a director, ratifying cost auditor remuneration of ₹6.00 Lakhs for FY 2026-27, and seeking approval for loans, guarantees, or securities up to ₹650 Cr to group entities and for overall company investments under Sections 185 and 186 of the Companies Act, 2013. — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_05082026213603_IntimationforNoticeofAGM.pdf)
- 2026-08-05 — Management Change: Krishna Institute of Medical Sciences Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/NOTICE_OF_SHAREHOLDERS_MEETINGS_19312_WebXMLFile_20260805_221928460.xml)
- 2026-08-05 — Generic Announcement: Krishna Institute of Medical Sciences Limited (KIMS) submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 on August 5, 2026, along with a Reasonable Assurance Report from Brahmayya & Co. The BRSR, which is part of the Integrated Annual Report, details the company's performance against the National Guidelines on Responsible Business Conduct and SEBI's BRSR framework, covering environmental stewardship, social responsibility, and governance. The report is available on the company's website. — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_05082026214454_BRSRfinal2026.pdf)
- 2026-08-05 — Generic Announcement: KIMS Hospitals submitted its Integrated Annual Report for FY 2025-26 on August 5, 2026. The report details significant expansion, including the launch of new hospitals in Bengaluru and Mumbai, and an increase in total units to 27 across five states. Financially, consolidated revenue grew by 28.2% to Rs. 39,308 million, while Profit After Tax (PAT) decreased by 41.7% to Rs. 2,420 million, attributed to initial gestation costs of expansion. The company also raised H1500 crores through a Qualified Institutional Placement (QIP) and H600 crores via preferential allotment to promoters. — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_05082026214239_Annualreportfinal.pdf)
- 2026-08-04 — Official Filing: Krishna Institute of Medical Sciences Limited (KIMS) will participate in the Emkay Confluence 2026, an institutional investor meet, on August 12, 2026, in Mumbai. The in-person group meeting, scheduled to start at 10:00 AM, will involve interaction with investors, including analyst Anshul from Emkay.
- 2026-08-04 — Generic Announcement: Krishna Institute of Medical Sciences Limited has published its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. This compliance notice was published in the Financial Express (English) and Navatelangana (Telugu) newspapers on August 4, 2026, and is also available on the company's website. — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_04082026161540_newspaperadvertisementfinal.pdf)
- 2026-08-04 — Generic Announcement: Krishna Institute of Medical Sciences Limited has made available the audio recording of its Q1 FY27 conference call with investors and analysts, held on August 7, 2025. The recording can be accessed on the company's website under the investor disclosures section. — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_04082026170949_Calllink.pdf)
- 2026-08-04 — Generic Announcement: Krishna Institute of Medical Sciences Limited will hold a group meeting on August 12, 2026, in Mumbai, India, as part of the Emkay Confluence 2026 event. No unpublished price sensitive information will be disclosed during this meeting. — [Official attachment](https://nsearchives.nseindia.com/corporate/KIMS_04082026170829_Investor_call_12082026.pdf)

## News and market events

- 2026-09-10 — CNBC-TV18: **KIMS enters O&M agreement to manage 183-bed Trust Hospital in Kakinada, Andhra Pradesh** — Shares of Krishna Institute of Medical Sciences Ltd ended at ₹774.00, up by ₹1.20, or 9.20%, on the BSE. — [Source](https://www.cnbctv18.com/market/stocks/kims-share-price-enters-om-agreement-to-manage-183-bed-trust-hospital-in-kakinada-andhra-pradesh-19988692.htm)
- 2026-08-21 — BUSINESSTODAY: **Top stocks in news: IndiGo, HAL, Amagi Labs, TMPV, Manipal Health, RailTel Corp, KIMS, Niva Bupa** — Top stocks in news: IndiGo, HAL, Amagi Labs, TMPV, Manipal Health, RailTel Corp, KIMS, Niva Bupa — [Source](https://www.businesstoday.in/markets/stocks/story/top-stocks-in-news-indigo-hal-amagi-labs-tmpv-manipal-health-railtel-corp-kims-niva-bupa-550478-2026-08-21)
- 2026-08-21 — Mint: **Stocks to watch: HAL, RailTel, Tata Motors PV among shares in focus today; check list here** — Stock market today: On Thursday, the Nifty 50 ended the session 0.55% higher at 24,211, meanwhile, Sensex gained 0.75% to settle at 77,488. — [Source](https://www.livemint.com/market/stock-market-news/stocks-to-watch-hal-railtel-tata-motors-pv-among-shares-in-focus-today-check-list-here-11787243365674.html)
- 2026-08-21 — MONEYCONTROL: **Stocks to Watch Today: Amagi Media Labs, Manipal Health, Saatvik Green Energy, RailTel Corp, Kfin Technologies, Krishna Institute of Medical Sciences in focus on 21 August** — Stocks to watch, stocks in focus today, stocks in focus, share market today, top stocks, shares in focus today, shares today, today stocks to watch, trending stocks, trending stocks today, markets today, buzzing stocks, stocks today, stock market today,Manipal Health Enterprises,Amagi Media Labs,Saatvik Green Energy,Torrent Power,Krishna Institute of Medical Sciences,RailTel Corporation of India,Lemon Tree Hotels,Rallis India,Kfin Technologies,Pfizer,Amrutanjan Health Care,Apollo Pipes,Welspun Investments and Commercials,Credent Connect N Care,Technocrats Plasma Systems, ENS Enterprises, Skytech Infinite Platform — [Source](https://www.moneycontrol.com/news/business/markets/stocks-to-watch-today-amagi-media-labs-manipal-health-saatvik-green-energy-railtel-corp-kfin-technologies-krishna-institute-of-medical-sciences-in-focus-on-21-august-14011891.html)
- 2026-08-20 — CNBC-TV18: **Stocks to Watch for August 21: RailTel, KIMS, Saatvik Green Energy, Manipal Health and more** — From Manipal Health’s Q1 results and Saatvik Green Energy’s ₹190 crore solar module order to RailTel’s ₹164.79 crore Western Coalfields order, Tata Motors PV’s Sanand operations update and Niva Bupa’s IRDAI action, here are the stocks to watch ahead of Friday market session. — [Source](https://www.cnbctv18.com/photos/market/stocks-to-watch-for-august-21-railtel-hal-kims-manipal-health-share-price-19973747.htm)
- 2026-08-20 — CNBC-TV18: **KIMS to operate 250-bed Arete Hospital in Hyderabad under 5-year O&M deal** — Shares of Krishna Institute of Medical Sciences Ltd ended at ₹788.00, down by ₹0.60, or 0.076%, on the BSE. — [Source](https://www.cnbctv18.com/market/stocks/kims-share-price-to-operate-250-bed-arete-hospital-in-hyderabad-under-5-year-om-deal-19973830.htm)
- 2026-08-04 — BUSINESSTODAY: **Top stocks in news: Paytm, SBI Funds, LIC, Meesho, DLF, Kalpataru, IREDA, Arvind, KIMS** — Stocks in news, Stocks in buzz, Stocks to buy, Stocks to watch, Paytm, SBI Funds, LIC of India, Meesho, DLF, Kalpataru, IREDA, Arvind, KIMS, GE Shipping, DOMS Industries, One 97 Communications, SBI Funds Management, Life Insurance Corporation of India, Indian Renewable Energy Development Agency, KEI Industries, Krishna Institute of Medical Sciences, Torrent Power, Texmaco Rail and Engineering, Great Eastern Shipping Company, UPL, GlaxoSmithKline Pharmaceuticals, Kansai Nerolac Paints, Thomas Cook (India), Gulf Oil Lubricants, VVIP Infratech, Restaurant Brands Asia — [Source](https://www.businesstoday.in/markets/stocks/story/top-stocks-in-news-paytm-sbi-funds-lic-meesho-dlf-kalpataru-ireda-arvind-kims-546987-2026-08-04)
- 2026-08-03 — CNBC-TV18: **KIMS Q1 profit falls 47% despite 35% revenue growth; bed capacity expands** — Krishna Institute of Medical Sciences reported strong revenue growth in the June quarter as new hospitals and higher patient volumes boosted operations, but profits declined due to margin pressure and other factors. — [Source](https://www.cnbctv18.com/market/earnings/kims-q1-profit-falls-47-despite-35-revenue-growth-bed-capacity-expands-19960785.htm)

## Business profile

**Strategic vision:** Operates a network of multi-specialty hospitals in India.

### Business segments
- **Healthcare Services:** The company provides comprehensive healthcare services across primary, secondary, and tertiary care. Its hospitals offer specialized treatments in cardiac sciences, neurosciences, oncology, orthopedics, renal sciences, and organ transplantation.

### Competitive strengths
- Operates a network of multi-specialty hospitals.

## Related stocks

- [360ONE (Financial Services)](https://faxioms.com/stocks/360one) — +1.96%
- [3MINDIA (Diversified)](https://faxioms.com/stocks/3mindia) — +5.50%
- [AADHARHFC](https://faxioms.com/stocks/aadharhfc) — -1.42%
- [AARTIIND](https://faxioms.com/stocks/aartiind) — +3.19%
- [AAVAS](https://faxioms.com/stocks/aavas) — -1.07%

## Freshness and sources

- Data as of: 2026-09-18
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/kims
Markdown representation: https://faxioms.com/stocks/kims?render=md